Very preterm birth: who has access to antenatal corticosteroid therapy?

Autor: Philippe Boisselier, Gérard Thiriez, Didier Riethmuller, Jean-Bernard Gouyon, Marie-France Bouthet, Claire Brousse, Alain Menget, Fabrice Pierre, Blandine Mulin, Guillaume Magnin, Simon Kayemba-Kay's, Béatrice Gouyon, A. Burguet, Robert Maillet, Paul Sanyas, Cyril Ferdynus, Paul Sagot

Publikováno v: Paediatric and Perinatal Epidemiology
Paediatric and Perinatal Epidemiology, Wiley, 2010, 24 (1), pp.63-74. 〈10.1111/j.1365-3016.2009.01090.x〉
Paediatric and Perinatal Epidemiology, Wiley, 2010, 24 (1), pp.63-74. ⟨10.1111/j.1365-3016.2009.01090.x⟩

International audience; We describe the administration of antenatal corticosteroid therapy (ACT) for liveborn very preterm neonates in a population-based study. A total of 790 very preterm neonates (between 24 and 31 full weeks of gestation) were inc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7ee633394e911e8dd46417be1acca4
https://hal.archives-ouvertes.fr/hal-00493352